Please assess the completion status of the following clinical trial:

Trial Title: Clinical Outcomes of Buffered vs. Non-Buffered Lidocaine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-30 years~* ASA I~* Willingness to complete QOL instrument~* Willingness to participate in two sessions~Exclusion Criteria:~* Allergy to lidocaine class of anesthetic drugs~* Local anesthetic drug use in past week~* Current symptoms teeth or oral mucosa

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- Buffered Lidocaine (Type: ACTIVE_COMPARATOR): In week One each subject would receive anesthetic to block the inferior alveolar and lingual N; Halstead or Gow-Gates techniques. No Buccal N. block.~Venous blood samples would be drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels
- Non-buffered Lidocaine (Type: ACTIVE_COMPARATOR): In week One each subject would receive anesthetic to block the inferior alveolar and lingual N; Halstead or Gow-Gates techniques. No Buccal N. block. At least a week later injections would involve the alternate local anesthetic combination.~Venous blood samples would be drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels

Based on this trial design, predict the completion outcome and termination type (if applicable).